Education
About Us
Working with TipRanks
Follow Us
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -516.75K | $ -98.61K | $ -42.47K | $ 0.00 | $ 0.00 |
| Operating Income | $ -19.42M | $ -18.67M | $ -6.15M | $ -726.60K | $ -456.87K |
| EBITDA | $ -17.97M | $ -17.47M | $ -6.11M | $ 0.00 | $ 0.00 |
| Net Income | $ -18.55M | $ -35.13M | $ -6.94M | $ -2.74M | $ -764.14K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.77M | $ 4.97M | $ 20.83M | $ 828.02K | $ 204.47K |
| Total Assets | $ 5.17M | $ 7.59M | $ 22.94M | $ 1.06M | $ 204.47K |
| Total Debt | $ 450.57K | $ 0.00 | $ 0.00 | $ 2.09M | $ 927.81K |
| Net Debt | $ -2.32M | $ -4.97M | $ -20.83M | $ 1.26M | $ 723.34K |
| Total Liabilities | $ 3.53M | $ 4.35M | $ 2.53M | $ 4.46M | $ 1.31M |
| Stockholders' Equity | $ 1.64M | $ 3.24M | $ 20.40M | $ -3.41M | $ -1.11M |
| Cash Flow | |||||
| Free Cash Flow | $ -18.11M | $ -15.86M | $ -5.52M | $ -492.97K | $ -508.51K |
| Operating Cash Flow | $ -18.07M | $ -15.76M | $ -5.27M | $ -492.97K | $ -508.51K |
| Investing Cash Flow | $ -35.61K | $ -100.92K | $ -251.82K | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 15.91M | $ 5.99K | $ 25.52M | $ 1.12M | $ 500.00K |